Amyl valerate is a simple aliphatic ester more precisely indexed in major databases as pentyl valerate or pentyl pentanoate. In AromaForge it is currently most useful as an occurrence marker in khella oil and as a flavor-fragrance identity record rather than a well-studied standalone bioactive. The public evidence base is thin for direct mechanism or toxicology, so the archive entry stays conservative and gap-labeled.
Aroma and practical use
- Use the recorded fruity, apple-like, sweet, ripe-fruit descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2024 public khella oil specification and COA listed amyl valerate among the main components at 4-12% by specification and 5.81% in one tested batch.
A 2024 public khella oil specification and COA listed amyl valerate among the main components at 4-12% by specification and 5.81% in one tested batch.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedIOFI's Global Reference List entry supports ongoing flavor-industry cataloging of pentyl valerate and links it to FL-No 09.149.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No constituent-specific human safety assessment, fragrance-panel review, or archive-ready topical limit was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
Expected ester hydrolysis by carboxylesterases
As with other low-molecular-weight esters, amyl valerate is expected to hydrolyze to pentanol and valeric acid under enzymatic metabolism. This is a class-based inference, not a direct constituent experiment.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Direct constituent-specific pharmacology or human-use literature was not located.
- The archive's source oil listed the constituent only as 'amyl valerate'; public chemical databases support CAS 2173-56-0 for the n-amyl/pentyl valerate interpretation, but source documents did not state the synonym set explicitly.
- No IFRA-style topical maximum or RIFM-style safety assessment was verified in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.